In patients with a diagnosis of early- or intermediate-stage nonneovascular age-related macular degeneration (AMD), exposure to levodopa was associated with a significantly reduced risk for conversion ...

The therapy is expected to block abnormal blood vessel growth, limit vascular leakage, and reduce retina damage. The Food and Drug Administration (FDA) has granted Fast Track designation to SAR402663 ...

Please provide your email address to receive an email when new articles are posted on . One presenter said at-home OCT has the potential to improve outcomes in neovascular AMD through personalized ...

Please provide your email address to receive an email when new articles are posted on . Patients with diabetes taking GLP-1s had a twofold higher risk for wet AMD development in unadjusted and ...

AMD primarily affects central vision, complicating activities like reading and driving, but does not cause complete blindness. Wet AMD involves abnormal blood vessel growth, while dry AMD progresses ...